Depression in pregnancy: Time to stop terrifying pregnant women

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Recent studies have powerfully demonstrated that women with depression, whether treated with SSRIs or skip treatment, report double risk of cardiovascular malformations. Yet, physicians and epidemiologists continue to terrify women who are at serious life threatening risks if not treated pharmacologically, with non evidence-based information. This paper calls for immediate stop of such practice.

Original languageEnglish
Pages (from-to)e369-e370
JournalJournal of Population Therapeutics and Clinical Pharmacology
Volume19
Issue number3
StatePublished - 2012
Externally publishedYes

Keywords

  • Drug therapy
  • Maternal depression
  • Pregnancy
  • Risk

Fingerprint

Dive into the research topics of 'Depression in pregnancy: Time to stop terrifying pregnant women'. Together they form a unique fingerprint.

Cite this